Patents by Inventor C. Seth PEARSON

C. Seth PEARSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220213428
    Abstract: The disclosure provides systems and methods for producing a cannabinoid product, which comprises contacting a cannabinoid precursor in a first phase with a cannabinoid synthase in a second phase, wherein the first phase and the second phase are substantially immiscible or immiscible. The disclosure also provides a composition comprising the cannabinoid precursor in a first phase and a cannabinoid synthase in a second phase, wherein the first phase and the second phase are substantially immiscible or immiscible.
    Type: Application
    Filed: March 21, 2022
    Publication date: July 7, 2022
    Applicant: TEEWINOT LIFE SCIENCES CORPORATION
    Inventors: Richard PEET, Malcolm J. KAVARANA, Mingyang SUN, Peter C. MICHELS, John D. RABENSTEIN, C. Seth PEARSON, Geoffrey M. FOX
  • Patent number: 11319525
    Abstract: The disclosure provides systems and methods for producing a cannabinoid product, which comprises contacting a cannabinoid precursor in a first phase with a cannabinoid synthase in a second phase, wherein the first phase and the second phase are substantially immiscible or immiscible. The disclosure also provides a composition comprising the cannabinoid precursor in a first phase and a cannabinoid synthase in a second phase, wherein the first phase and the second phase are substantially immiscible or immiscible.
    Type: Grant
    Filed: June 26, 2019
    Date of Patent: May 3, 2022
    Assignee: TEEWINOT LIFE SCIENCES CORPORATION
    Inventors: Richard Peet, Malcolm J. Kavarana, Mingyang Sun, Peter C. Michels, John D. Rabenstein, C. Seth Pearson, Geoffrey M. Fox
  • Publication number: 20220125057
    Abstract: Disclosed herein are novel anti-microbial peptides with inhibitory activity against M. tuberculosis and streptococcus bacteria. Additionally, a method for designing novel anti-microbial peptides is disclosed.
    Type: Application
    Filed: November 10, 2021
    Publication date: April 28, 2022
    Applicants: RENSSELAER POLYTECHNIC INSTITUTE, HEALTH RESEARCH, INC.
    Inventors: Georges BELFORT, C. Seth PEARSON, Brian MURRAY, Pankaj Sakharam KARANDE, Jun Ha KWAK, Kathleen A. MCDONOUGH, Zachary Andrew KLOOS
  • Patent number: 11202449
    Abstract: Disclosed herein are novel anti-microbial peptides with inhibitory activity against M. tuberculosis and streptococcus bacteria. Additionally, a method for designing novel anti-microbial peptides is disclosed.
    Type: Grant
    Filed: May 14, 2019
    Date of Patent: December 21, 2021
    Assignees: Rensselaer Polytechnic Institute, Health Research, Inc.
    Inventors: Georges Belfort, C. Seth Pearson, Brian Murray, Pankaj Sakharam Karande, Jun Ha Kwak, Kathleen A. McDonough, Zachary Andrew Kloos
  • Publication number: 20190382708
    Abstract: The disclosure provides systems and methods for producing a cannabinoid product, which comprises contacting a cannabinoid precursor in a first phase with a cannabinoid synthase in a second phase, wherein the first phase and the second phase are substantially immiscible or immiscible. The disclosure also provides a composition comprising the cannabinoid precursor in a first phase and a cannabinoid synthase in a second phase, wherein the first phase and the second phase are substantially immiscible or immiscible.
    Type: Application
    Filed: June 26, 2019
    Publication date: December 19, 2019
    Inventors: Richard PEET, Malcolm J. KAVARANA, Mingyang SUN, Peter C. Michels, John D. Rabenstein, C. Seth Pearson, Geoffrey M. Fox
  • Publication number: 20190337984
    Abstract: Disclosed herein are novel anti-microbial peptides with inhibitory activity against M. tuberculosis and streptococcus bacteria. Additionally, a method for designing novel anti-microbial peptides is disclosed.
    Type: Application
    Filed: May 14, 2019
    Publication date: November 7, 2019
    Applicant: RENSSELAER POLYTECHNIC INSTITUTE
    Inventors: Georges BELFORT, C. Seth PEARSON, Brian MURRAY, Pankaj Sakharam KARANDE, Jun Ha KWAK, Kathleen A. MCDONOUGH, Zachary Andrew KLOOS
  • Patent number: 10336790
    Abstract: Disclosed herein are novel anti-microbial peptides with inhibitory activity against M. tuberculosis and streptococcus bacteria. Additionally, a method for designing novel anti-microbial peptides is disclosed.
    Type: Grant
    Filed: September 8, 2016
    Date of Patent: July 2, 2019
    Assignee: Rensselaer Polytechnic Institute
    Inventors: Georges Belfort, C. Seth Pearson, Brian Murray, Pankaj Sakharam Karande, Jun Ha Kwak, Kathleen A. McDonough, Zachary Andrew Kloos
  • Patent number: 10336978
    Abstract: The disclosure provides systems and methods for producing a cannabinoid product, which comprises contacting a cannabinoid precursor in a first phase with a cannabinoid synthase in a second phase, wherein the first phase and the second phase are substantially immiscible or immiscible. The disclosure also provides a composition comprising the cannabinoid precursor in a first phase and a cannabinoid synthase in a second phase, wherein the first phase and the second phase are substantially immiscible or immiscible.
    Type: Grant
    Filed: May 10, 2018
    Date of Patent: July 2, 2019
    Assignee: TEEWINOT TECHNOLOGIES LIMITED
    Inventors: Richard Peet, Malcolm J. Kavarana, Mingyang Sun, Peter C. Michels, John D. Rabenstein, C. Seth Pearson, Geoffrey M. Fox
  • Publication number: 20180346866
    Abstract: The disclosure provides systems and methods for producing a cannabinoid product, which comprises contacting a cannabinoid precursor in a first phase with a cannabinoid synthase in a second phase, wherein the first phase and the second phase are substantially immiscible or immiscible. The disclosure also provides a composition comprising the cannabinoid precursor in a first phase and a cannabinoid synthase in a second phase, wherein the first phase and the second phase are substantially immiscible or immiscible.
    Type: Application
    Filed: May 10, 2018
    Publication date: December 6, 2018
    Applicant: TEEWINOT TECHNOLOGIES LIMITED
    Inventors: Richard PEET, Malcolm J. KAVARANA, Mingyang SUN, Peter C. Michels, John D. Rabenstein, C. Seth Pearson, Geoffrey M. Fox
  • Publication number: 20160376320
    Abstract: Disclosed herein are novel anti-microbial peptides with inhibitory activity against M. tuberculosis and streptococcus bacteria. Additionally, a method for designing novel anti-microbial peptides is disclosed.
    Type: Application
    Filed: September 8, 2016
    Publication date: December 29, 2016
    Applicant: RENSSELAER POLYTECHNIC INSTITUTE
    Inventors: Georges BELFORT, C. Seth PEARSON, Brian MURRAY, Pankaj Sakharam KARANDE, Jun Ha KWAK, Kathleen A. MCDONOUGH, Zachary Andrew KLOOS